Heart Disease :: Improve the safety of implantable cardiac devices

In its ongoing commitment to improve the safety monitoring of implantable cardiac devices and provide earlier notice to doctors and patients of potential problems, the U.S. Food and Drug Administration (FDA) released its retrospective review of malfunctions of implantable cardioverter defibrillators (ICD) and pacemakers occurring from 1990-2002. The findings were presented at the Heart Rhythm Society “Policy Conference on Pacemaker and ICD Performance,” in Washington, DC.